VevaRx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.5/10
Best for: published plan prices from month-to-month to 12 months, in the 36 states it lists
VevaRx scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care, and it serves 36 states. It charges from $47 a month, paid up front; its compounded semaglutide, at $120, is 40% below the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
charged as a multi-month plan up front
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
VevaRx LLC sells compounded semaglutide at $120 a month and compounded tirzepatide at $189 a month, with 3-, 6- and 12-month plans that cut the monthly rate to as little as $47 and $87, billed up front. Clinical care runs through TelegraMD, and its FAQ lists 36 states. It also sells sermorelin, glutathione, NAD+ and PT-141. The terms describe only an unnamed independent compounding pharmacy.
Is VevaRx legit?
Yes. VevaRx is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 8.5/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a VevaRx promo or coupon code?
We know of no promo or coupon code for VevaRx. Its listed price is $47 a month. Coupon sites advertising "VevaRx discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how VevaRx compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to VevaRx
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
VevaRx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $47/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- What's included
- Medication · Consult · Shipping
- Availability
- 36 states
- FDA status
- No FDA warning letters found
How VevaRx scores
Six columns, each one computed from something VevaRx has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
8.6/10$120/month is 40% below the $199 median for compounded semaglutide across the sellers we compare. A cheaper plan paid several months up front is also listed.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
7.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
7.8/10Serves 36 of 50 states.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on VevaRx
Last checked October 2026- Checked the listed price across 8 dose or plan tiers
- Checked state coverage: 36 states
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for VevaRx
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with VevaRx involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1VevaRx shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask VevaRx which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $47, tirzepatide $87. That leaves out membership fees, first-month rates and insurance copays.
- VevaRx serves 36 of 50 states, so check that yours is one of them.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Cancelling VevaRx
Taken from the terms VevaRx publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- Monthly plan has no term; longer plans charge the whole term at checkout
- Refund policy
- Refund minus a $25 consultation fee if canceled after approval but before the order goes to the pharmacy; none after
- Early-termination fee
- None
Medications VevaRx lists
VevaRx lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
Semaglutide page: "Month-to-month $120 billed monthly".
Semaglutide page: "3 months $267 billed every 3 months ... $89".
Semaglutide page: "6 months $430 billed every 6 months ... $72".
Semaglutide page: "12 months BEST VALUE $564 billed every 12 months ... $47 per month".
Tirzepatide page: "Month-to-month $189 billed monthly"; also "Month-to-month: $189 per month".
Tirzepatide page: "3 months $447 billed every 3 months ... $149".
Tirzepatide page: "6 months $767 billed every 6 months ... $128".
Tirzepatide page: "12 months BEST VALUE $1,044 billed every 12 months ... $87 per month".
Check the price yourself before you pay
Every figure here comes from VevaRx's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $120 a month, 40% below the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $189 a month, 30% below the $269 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to VevaRx
Against it
- Serves only 36 states, so check that yours is one of them
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What VevaRx charges
The standing price at VevaRx is $47/month, unchanged as the dose goes up. Flat dose pricing matters more than it sounds: on a tiered plan the bill grows with the dose, so the figure that got you to sign up is not the one you end up paying.
- Compounded semaglutide (monthly): $120/month
- Compounded semaglutide (3-month plan): $89/month
- Compounded semaglutide (6-month plan): $71.67/month
- Compounded semaglutide (12-month plan): $47/month
- Compounded tirzepatide (monthly): $189/month
- Compounded tirzepatide (3-month plan): $149/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so VevaRx's $120 is genuinely below the middle, not just advertised that way. Some of VevaRx's plans are paid several months up front, so read the terms you agree to at checkout before you choose a longer one. For scale, the dearest tenth of compounded sellers charges about three times the cheapest tenth.
WellMedRx, at about $49/month, is the closest like-for-like alternative we review.
What VevaRx dispenses
VevaRx prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. For what differs besides the price, see compounded semaglutide vs Ozempic and Wegovy.
Safety and disclosure
VevaRx tells you its price before you start the medical questionnaire and the 36 states it serves. We found no FDA warning letters issued to VevaRx. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If VevaRx will not tell you, treat that as a warning sign. Once you have the pharmacy's name, 503A vs 503B explains which regulator oversees it and how to check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether VevaRx bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want the price to stop moving as your dose climbs
Our read
VevaRx competes on price without an obvious sacrifice elsewhere: $120/month for compounded semaglutide, no FDA warning letters.
The Bottom Line
VevaRx scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care, and it serves 36 states. It charges from $47 a month, paid up front; its compounded semaglutide, at $120, is 40% below the $199 median among the sellers we compare.
Before you pay VevaRx
Starting at $47 a month. Check today's price, then start the intake.
Where VevaRx is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If you want a human checking in, not just a prescription, consider Eden.
- If your state is outside the area this one covers, consider Embody.
If none of these fits, our guide to alternatives to VevaRx sets more sellers in the same category beside VevaRx on price, states and what the price includes.
Frequently Asked Questions
How to check VevaRx yourself
- We Read FDA's Register of Compounding Facilities. 43 of 100 Have Never Been Inspected.
- How to Get a GLP-1 Prescription
- FDA Warning Letters to Peptide Sellers: What FDA Has Cited, 2023 to 2026
Every seller that ships to your state, side by side: Idaho, Kentucky, Massachusetts, Minnesota, Montana, Nebraska, New Hampshire, North Carolina and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this VevaRx review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See VevaRx's current pricing
Plans start at $47 a month. Whether you qualify is a clinician's decision, made after your intake.